News from the FDA/CDC

Operation Quack Hack: FDA moves to stop fraudulent COVID-19 products


 

No form of human misery can be allowed to go unexploited, and the pandemic, it seems, is no exception.

Operation Quack Hack

As part of Operation Quack Hack, the Food and Drug Administration has stepped up its investigation and enforcement efforts against companies and individuals that are “taking advantage of widespread fear among consumers during the COVID-19 pandemic” by selling fake products and treatments for coronavirus.

As of May 7, 2020, the agency had issued 42 warning letters to companies that were “selling unapproved products that fraudulently claim to mitigate, prevent, treat, diagnose or cure COVID-19,” the FDA announced in a written statement. Of those 42 products, 29 are no longer being sold with any sort of COVID-19 claim.

Since the beginning of the pandemic, Operation Quack Hack has uncovered hundreds of such products – drugs, testing kits, and personal protective equipment – being sold online, and complaints were sent to domain-name registrars and Internet marketplaces that have, in most cases, removed the postings, the FDA said.

“We will continue to monitor the online ecosystem for fraudulent products peddled by bad actors seeking to profit from this global pandemic. We encourage anyone aware of suspected fraudulent medical products for COVID-19 to report them to the FDA,” the statement said.

Recommended Reading

New angiotensin studies in COVID-19 give more reassurance
Clinician Reviews
COVID-19 pulmonary severity ascribed to coagulation differences
Clinician Reviews
COVID-19–associated coagulopathy
Clinician Reviews
Results from 11 AHA-funded COVID-19 studies expected within months
Clinician Reviews
More guidance on inpatient management of blood glucose in COVID-19
Clinician Reviews
COVID-19: Eight steps for getting ready to see patients again
Clinician Reviews
Pandemic-related stress rising among ICU clinicians
Clinician Reviews
Androgens may explain male vulnerability to COVID-19
Clinician Reviews
Novel inflammatory syndrome in children possibly linked to COVID-19
Clinician Reviews
U.S. ‘deaths of despair’ from COVID-19 could top 75,000, experts warn
Clinician Reviews